Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/05/23 → 1/05/26 |
Funding
- Boehringer Ingelheim International GmbH: £341,885.34
Immunotherapeutic enhancement through inhibition of alternative splicing
- Myant, Kevin (Principal Investigator)
| Status | Active |
|---|---|
| Effective start/end date | 1/05/23 → 1/05/26 |